A carregar...
Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a VEGFR2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial
BACKGROUND: Germ cell tumors (GCT) are the most common solid tumors in adolescent and young adult males (age 15 and 35 years) and remain one of the most curable of all solid malignancies. However a subset of patients will have tumors that are refractory to standard chemotherapy agents. The managemen...
Na minha lista:
Publicado no: | J Hematol Oncol |
---|---|
Main Authors: | , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
BioMed Central
2014
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4237879/ https://ncbi.nlm.nih.gov/pubmed/25085632 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-014-0052-x |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|